Potent_NN
gene_NN
regulatory_JJ
and_CC
antiproliferative_JJ
activities_NNS
of_IN
20-methyl_JJ
analogs_NNS
of_IN
1,25_CD
dihydroxyvitamin_NN
D3_NN
._.

The_DT
biological_JJ
active_JJ
form_NN
of_IN
vitamin_NN
D3_NN
,_,
1,25-dihydroxyvitamin_NN
D3_NN
-LRB-_-LRB-
VD_NN
-RRB-_-RRB-
,_,
regulates_VBZ
cellular_JJ
growth_NN
and_CC
differentiation_NN
._.

This_DT
provides_VBZ
the_DT
hormone_NN
with_IN
an_DT
interesting_JJ
therapeutic_JJ
potential_NN
._.

However_RB
,_,
hypercalcemia_NN
is_VBZ
a_DT
side_JJ
effect_NN
,_,
which_WDT
is_VBZ
caused_VBN
by_IN
VD_NN
's_POS
classical_JJ
action_NN
,_,
the_DT
regulation_NN
of_IN
calcium_NN
homeostasis_NN
._.

This_DT
made_VBD
the_DT
need_NN
for_IN
VD_NN
analogs_NNS
with_IN
selectively_RB
increased_VBN
cell_NN
regulatory_JJ
properties_NNS
._.

Studies_NNS
with_IN
20-epi_JJ
analogs_NNS
pointed_VBD
out_RP
the_DT
importance_NN
of_IN
the_DT
carbon-20_NN
position_NN
and_CC
led_VBD
to_TO
the_DT
development_NN
of_IN
20-methyl_JJ
derivatives_NNS
of_IN
VD_NN
._.

In_IN
this_DT
report_VBP
the_DT
biological_JJ
properties_NNS
of_IN
the_DT
compounds_NNS
ZK161422_NN
and_CC
ZK157202_NN
,_,
which_WDT
are_VBP
20-methyl_NN
-_:
and_CC
20-methyl-23-eneanalogues_NN
,_,
respectively_RB
,_,
have_VBP
been_VBN
analyzed_VBN
in_IN
comparison_NN
with_IN
VD_NN
._.

Both_DT
compounds_NNS
show_VBP
about_RB
2-fold_JJ
lower_JJR
affinity_NN
to_TO
the_DT
VD_NN
receptor_NN
-LRB-_-LRB-
VDR_NN
-RRB-_-RRB-
than_IN
VD_NN
._.

However_RB
,_,
compared_VBN
to_TO
VD_NN
,_,
their_PRP$
antiproliferative_JJ
effect_NN
is_VBZ
up_RB
to_TO
30-fold_RB
higher_JJR
on_IN
human_JJ
peripheral_JJ
blood_NN
mononuclear_JJ
cells_NNS
and_CC
even_RB
up_RB
to_TO
300-fold_CD
higher_JJR
on_IN
human_JJ
breast_NN
cancer_NN
MCF-7_NN
cells_NNS
._.

Whereas_IN
the_DT
hypercalcemic_JJ
effect_NN
for_IN
ZK157202_NN
is_VBZ
also_RB
increased_VBN
10-fold_RB
,_,
ZK161422_NN
has_VBZ
the_DT
same_JJ
calcium-mobilizing_JJ
potency_NN
as_IN
VD_NN
._.

Moreover_RB
,_,
ZK161422_NN
,_,
but_CC
not_RB
ZK157202_NN
,_,
showed_VBD
preference_NN
for_IN
gene_NN
activation_NN
from_IN
a_DT
promoter_NN
carrying_VBG
a_DT
VD_NN
response_NN
element_NN
with_IN
a_DT
palindromic_JJ
arrangement_NN
of_IN
two_CD
hexameric_JJ
receptor_NN
binding_NN
sites_NNS
spaced_VBN
by_IN
9_CD
nucleotides_NNS
-LRB-_-LRB-
IP9_NN
-RRB-_-RRB-
rather_RB
than_IN
for_IN
activation_NN
from_IN
a_DT
response_NN
element_NN
formed_VBN
by_IN
a_DT
direct_JJ
repeat_NN
spaced_VBN
by_IN
3_CD
nucleotides_NNS
-LRB-_-LRB-
DR3_NN
-RRB-_-RRB-
._.

This_DT
observation_NN
supports_VBZ
a_DT
model_NN
,_,
in_IN
which_WDT
promoter_NN
selectivity_NN
reflects_VBZ
the_DT
selectively_RB
increased_VBN
antiproliferative_JJ
effect_NN
of_IN
VD_NN
analogs_NNS
._.

